ArticlePLoS computational biology2025
Unsupervised detection and fitness estimation of emerging SARS-CoV-2 variants: Application to wastewater samples (ANRS0160).
Article in PLoS computational biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Varaps: a python package for estimating SARS-CoV-2 lineages proportions from pooled sequencing data (ANRS0160).BMC bioinformatics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Repeated waves of emerging variants during the SARS-CoV-2 pandemics have highlighted the urge of collecting longitudinal genomic data and developing statistical methods based on time series analyses for detecting new threatening lineages and estimating their fitness early in time. Most models study the evolution of the prevalence of particular lineages over time and require a prior classification of sequences into lineages which is prone to induce delays and biases. More recently, several authors studied the evolution of the prevalence of mutations over time with alternative clustering approaches, avoiding specific lineage classification. Most existing methods are either non parametric or unsuited to pooled data characterizing, for instance, wastewater samples. The analysis of wastewater samples has recently been pointed out as a valuable complementary approach to clinical sample analysis, however the pooled nature of the data involves specific statistical challenges. In this context, we propose an alternative unsupervised method for clustering mutations according to their frequency trajectory over time and estimating group fitness from time series of pooled mutation prevalence data. Our model is a mixture of observed count data and latent group assignment and we use the expectation-maximization algorithm for model selection and parameter estimation. The application of our method to time series of SARS-CoV-2 sequencing data collected from wastewater treatment plants in France from October 2020 to April 2021 shows its ability to agnostically group mutations in a consistent way with lineages B.1.160, Alpha, B.1.177, Beta, and with selection coefficient estimates per group in coherence with the viral dynamics in France reported by Nextstrain. Moreover, our method detected the Alpha variant as threatening as early as supervised methods (which track specific mutations over time) with the noticeable difference that, since unsupervised, it does not require any prior information on the set of mutations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.